Biocon share price today, January 31: The share price of Biocon has fallen more than 5% in the last five trading days. (Image: Freepik) The share price of Biocon rose almost 4% to an intra-day ...

HYDERABAD, Jan 30 (Reuters) - Indian biopharma company Biocon (BION.NS), opens new tab reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period ...

HYDERABAD -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for a double-digit share in its core U.S. market for its new launches ...

Shares of Biocon popped up 8.5% in trade on Tuesday, January 07, to hit ₹389 apiece, a level not seen since mid-September, driven by multiple positive developments. The company informed ...

The pro-localisation policy in the US will not impact Biocon Biologics’ revenue, noted Shreehas Tambe, CEO of Biocon Biologics. The US, which contributes 40 per cent of the company’s revenue ...

International brokerage Jefferies has upgraded its rating on drugmaker Biocon to 'hold' citing positive newsflow around the regulatory approval of its Bengaluru manufacturing unit. Building on the ...

Biocon in its Environmental, Social and Governance (ESG) scores as assessed by S&P Global’s Corporate Sustainability Assessment (CSA) for 2024 has achieved an improvement to 69 in 2024, up 6 points ...

HYDERABAD, Jan 31 (Reuters) - Indian biopharmaceutical firm Biocon (BION.NS), opens new tab is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core ...

HYDERABAD (Reuters) -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a ...

Shares of Biocon saw a significant surge of over 7 percent on Tuesday, January 14, 2025, following an upgrade by global brokerage firm HSBC. The firm raised its rating on the stock to ‘Buy ...

Kiran shares her visionary journey, insights, and innovations in advancing biotechnology through the development of Biocon.

Kiran shares her journey, vision, and the innovations that have driven Biocon's growth and impact in the biotechnology sector.